104 related articles for article (PubMed ID: 10446447)
1. The role of immunosuppression and immune-activation in classic Kaposi's sarcoma.
Touloumi G; Hatzakis A; Potouridou I; Milona I; Strarigos J; Katsambas A; Giraldo G; Beth-Giraldo E; Biggar RJ; Mueller N; Trichopoulos D
Int J Cancer; 1999 Sep; 82(6):817-21. PubMed ID: 10446447
[TBL] [Abstract][Full Text] [Related]
2. Association of clinical progression in classic Kaposi's sarcoma with reduction of peripheral B lymphocytes and partial increase in serum immune activation markers.
Stratigos AJ; Malanos D; Touloumi G; Antoniou A; Potouridou I; Polydorou D; Katsambas AD; Whitby D; Mueller N; Stratigos JD; Hatzakis A
Arch Dermatol; 2005 Nov; 141(11):1421-6. PubMed ID: 16301389
[TBL] [Abstract][Full Text] [Related]
3. Immunological profile of endemic and epidemic Kaposi's sarcoma patients in Dar-es-Salaam, Tanzania.
Urassa WK; Kaaya EE; Kitinya JN; Lema LL; Amir H; Luande J; Biberfeld G; Mhalu FS; Biberfeld P
Int J Mol Med; 1998 Jun; 1(6):979-82. PubMed ID: 9852634
[TBL] [Abstract][Full Text] [Related]
4. A fifth subtype of Kaposi's sarcoma, classic Kaposi's sarcoma in men who have sex with men: a cohort study in Paris.
Denis D; Seta V; Regnier-Rosencher E; Kramkimel N; Chanal J; Avril MF; Dupin N
J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):1377-1384. PubMed ID: 29377280
[TBL] [Abstract][Full Text] [Related]
5. Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS.
Krown SE; Niedzwiecki D; Bhalla RB; Flomenberg N; Bundow D; Chapman D
J Acquir Immune Defic Syndr (1988); 1991; 4(9):871-80. PubMed ID: 1895208
[TBL] [Abstract][Full Text] [Related]
6. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
7. Urinary neopterin and immunological features in patients with Kaposi's sarcoma.
Santelli G; Melillo G; Marfella A; Napolitano M; D'Alessio V; Satriano RA; Beth-Giraldo E; Giraldo G; Perna M; Castello G
Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1391-6. PubMed ID: 3263274
[TBL] [Abstract][Full Text] [Related]
8. Relationship of serum levels of oncostatin M to AIDS-related and classic Kaposi's sarcoma.
Hamilton AS; Radka SF; Bernstein L; Gill PS; Gonsalves M; Naemura JR; Ross RK
J Acquir Immune Defic Syndr (1988); 1994 Apr; 7(4):410-4. PubMed ID: 7907664
[TBL] [Abstract][Full Text] [Related]
9. CD4+ and CD8+ T-cell skewness in classic Kaposi sarcoma.
Galleu A; Fozza C; Simula MP; Contini S; Virdis P; Corda G; Pardini S; Cottoni F; Pruneddu S; Angeloni A; Ceccarelli S; Longinotti M
Neoplasia; 2012 Jun; 14(6):487-94. PubMed ID: 22787430
[TBL] [Abstract][Full Text] [Related]
10. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
[TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma developed in a patient with a thymoma in the setting of excess numbers of CD8-positive cells in the peripheral blood.
Sawai T; Tuchikawa K
Arch Pathol Lab Med; 1990 Jun; 114(6):611-3. PubMed ID: 1971744
[TBL] [Abstract][Full Text] [Related]
12. Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression.
Schechter M; Harrison LH; Halsey NA; Trade G; Santino M; Moulton LH; Quinn TC
JAMA; 1994 Feb; 271(5):353-7. PubMed ID: 7904317
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD40L on CD4
Ngalamika O; Kawimbe M; Mukasine MC
Cancer Treat Res Commun; 2021; 27():100361. PubMed ID: 33799006
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus-related microvasculopathy and Kaposi's sarcoma: a case-control study.
Baumann S; Geier SA; Thoma-Gerber E; Noehl MA; Klauss V; Goebel FD
Ger J Ophthalmol; 1995 Jul; 4(4):239-45. PubMed ID: 7492937
[TBL] [Abstract][Full Text] [Related]
15. Distribution of immunocompetent cells in oral Kaposi's sarcoma (AIDS).
Tabata M; Langford A; Becker J; Reichart PA
Eur J Cancer B Oral Oncol; 1993 Jul; 29B(3):209-13. PubMed ID: 7905311
[TBL] [Abstract][Full Text] [Related]
16. Predictors and reference values of CD4 and CD8 T lymphocyte counts in pregnancy: a cross sectional study among HIV negative women in Zimbabwe.
Gomo E; Vennervald BJ; Ndhlovu P; Kaestel P; Nyazema N; Friis H
Cent Afr J Med; 2004; 50(1-2):10-9. PubMed ID: 15490719
[TBL] [Abstract][Full Text] [Related]
17. Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma.
Brown EE; Whitby D; Vitale F; Marshall V; Mbisa G; Gamache C; Lauria C; Alberg AJ; Serraino D; Cordiali-Fei P; Messina A; Goedert JJ
Cancer; 2006 Nov; 107(9):2282-90. PubMed ID: 16998933
[TBL] [Abstract][Full Text] [Related]
18. Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific.
Krämer A; Biggar RJ; Hampl H; Friedman RM; Fuchs D; Wachter H; Goedert JJ
Am J Epidemiol; 1992 Jul; 136(1):71-80. PubMed ID: 1384311
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of seasonal influenza vaccination in patients with classic Kaposi's sarcoma.
Cappelletti M; Taddeo A; Colombo E; Brambilla L; Bellinvia M; Pregliasco F; Villa ML; Della Bella S
J Invest Dermatol; 2012 Oct; 132(10):2414-2421. PubMed ID: 22622418
[TBL] [Abstract][Full Text] [Related]
20. Cellular immune responses and disease control in acute AIDS-associated Kaposi's sarcoma.
Bihl F; Berger C; Chisholm JV; Henry LM; Bertisch B; Trojan A; Nadal D; Speck RF; Flepp M; Brander C; Mueller NJ;
AIDS; 2009 Sep; 23(14):1918-22. PubMed ID: 19609199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
